This approval was also confirmed by ABC News reporting
Post-reconstitution stability ~28 days at 28 C, protected from light (copper complex is photosensitive)

Risk factors that may influence the decision to pause treatment include: Being in the dose-escalation phase of GLP-1 therapy Experiencing active gastrointestinal symptoms (nausea, vomiting, bloating) Having known gastroparesis or other conditions affecting gastric emptying Taking concurrent medications that further delay gastric emptying (e.g., opioids) Undergoing procedures with higher aspiration risk (e.g., emergency surgery, airway surgery) If your anaesthetist or surgical team advises temporary cessation based on your individual risk assessment, the timing will depend on the specific medication: Daily injections (such as liraglutide): Typically paused 24 hours before surgery Weekly injections (such as semaglutide, dulaglutide): Often paused with the last dose given at least 7 days before surgery Oral semaglutide (Rybelsus): Usually paused 24 hours before surgery [4] However, these timings may vary according to local NHS Trust protocols and individual clinical assessment

Thus, these findings demonstrate the ability of TNBS to spontaneously complex free reduced GSH resulting in its almost instantaneous disappearance
Documentation: Keep a daily log of dose, injection site, and any observed effects to maintain protocol consistency and identify tolerance patterns
By promoting VEGF and NO signaling, these agents enhance angiogenic potential that may translate into improved microvascular integrity